Bone Marrow Transplant Recipients During Childhood at Increased Risk for Severe Chronic Health Conditions
Patients who underwent allogeneic bone marrow transplantation (BMT) as children were at increased risk for severe or life-threatening chronic health conditions. These findings were presented during the American Society of Hematology (ASH) 62nd Annual Meeting and Exposition.
Oral Azacitidine Improves, Sustains Health-Related QoL in AML
Treatment with the oral agent showed sustained health-related quality of life compared with placebo in patients with
Significant Racial, Ethnic Related Socioeconomic Disparities Influence Survival in AML
Existing agents, novel agents, or transplantation for high-risk MDS
Journal Title:
Hematology. American Society of Hematology. Education Program
Original Publication Date:
Dec 2020
The decision algorithm for treatment of advanced myelodysplastic syndrome (MDS) (intermediate- to very high-risk by the revised International Prognostic Scoring System [IPSS-R]) is complex.
Bone Marrow Disease(s):
Therapy for lower-risk MDS
Journal Title:
Hematology. American Society of Hematology. Education Program
Original Publication Date:
Dec 2020
Bone Marrow Disease(s):
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
Journal Title:
Blood Advances
Original Publication Date:
Nov 2020
Bone Marrow Disease(s):
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes
Journal Title:
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
Original Publication Date:
Nov 2020
Bone Marrow Disease(s):
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?
Journal Title:
Leukemia & Lymphoma
Original Publication Date:
Nov 2020
Bone Marrow Disease(s):
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map
Journal Title:
Hematology. American Society of Hematology. Education Program
Original Publication Date:
Dec 2020
Bone Marrow Disease(s):